All Videos

Hilary Baldwin, M.D., shares her hopes for the future of acne treatment and provides her practice pearls from a panel discussion surrounding the management of patients suffering from acne.

An expert in acne management shares her insight on the current needs and the role of consensus guidelines in the management of patients suffering from acne.

Dr Hilary Baldwin discusses her treatment considerations and approach in the management of patients with mild to moderate acne, highlighting the benefit of combination therapy.

Hilary Baldwin, M.D., comments on the impact of the recent approval of clascoterone cream 1% in the topical acne armamentarium of patients suffering from acne.

Aaron S. Farberg, MD, and Jeffrey Crowley, MD, share take-home messages on the impact of the generalized pustular psoriasis study.

Aaron S. Farberg, MD, and Jeffrey Crowley, MD, discuss study limitations regarding health records in generalized pustular psoriasis and how the number of flares could be underestimated.

Raj Chovatiya, MD, PhD, gives a preview of his discussions on topical formulations of atopic dermatitis and advancing therapeutic expectations at this weekend’s RAD conference.

Mona Shahriari, MD, Assistant Clinical Professor of Dermatology at Yale University School of Medicine, shares what she is looking forward to at the Revolutionizing Atopic Dermatitis virtual conference.

Korey Capozza, MPH, Executive Director of Global Parents for Eczema Research, shares what she is looking forward to at the Revolutionizing Atopic Dermatitis virtual conference.

Jonathan Silverberg, MD, PHD, MPHS, talks about the exciting highlights of the Revolutionizing Atopic Dermatitis virtual conference on December 11.

David Goldberg, MD, JD, shares some of the highlights that will be presented at this year's South Beach Symposium in Miami Beach, Florida.

Patricia Farris, MD, shares some of the highlights that will be presented at the 2023 South Beach Symposium in Miami Beach, Florida.

In this week’s Pointers with Dr Portela, the 208SkinDoc, reviews how some medications increase sun sensitivity.

Experts in dermatology discuss ruxolitinib, an exciting new therapy approved for repigmentation of the skin for patients with vitiligo.

Nada Elbuluk, MD, and David Rosmarin, MD, review treatments in vitiligo, including corticosteroids and phototherapy.

Aaron S. Farberg, MD, and Jeffrey Crowley, MD, discuss the importance of investigating the data on generalized pustular psoriasis, comorbidities of the disease, and commonly used treatments.

Experts in dermatology review data on various treatment interventions before, during, and after generalized pustular psoriasis flare episodes.

In this week’s Pointers with Dr Portela, the 208SkinDoc, asks consumers about the basics of skin health and skin care.

Nada Elbuluk, MD, and David Rosmarin, MD, discuss the role of the health care provider in helping patients understand their vitiligo and treatment options.

Experts in dermatology share their approaches to communicating with patients about their vitiligo, highlighting family history and genetic awareness.

Drs Mark G. Lebwohl and Alice B. Gottlieb discuss future expectations in the treatment of plaque psoriasis.

Aaron S. Farberg, MD, and Jeffrey Crowley, MD, examine the results of a study of generalized pustular psoriasis, discussing flares and common signs and symptoms.

Aaron S. Farberg, MD, and Jeffrey Crowley, MD, review the demographics of people with generalized pustular psoriasis including age, race, and comorbidities.

Following the 2022 Fall Clinical Dermatology meeting, Zoe Diana Draelos, MD; Mark G. Lebwohl, MD; Peter A. Lio, MD; and Elizabeth Swanson, MD, and engage in a rapid-fire question-and-answer sessions, hosted by Dermatology Times. Topics include most surprising new data, what needs follow-up, and the biggest winner out of the meeting.

Nada Elbuluk, MD, and David Rosmarin, MD, discuss screening patients with vitiligo for common comorbidities.

Nada Elbuluk, MD, and David Rosmarin, MD, provide an overview of vitiligo, its prevalence, and potential triggers.

Raj Chovatiya, MD, PhD, and Lisa Swanson, MD, FAAD, explore the impact of recent advances in atopic dermatitis treatment and look to future possibilities.

Raj Chovatiya, MD, PhD, and Lisa Swanson, MD, FAAD, review the challenges of identifying the right regimens for patients and the many factors that influence treatment selection.

Raj Chovatiya, MD, PhD, and Lisa Swanson, MD, FAAD, discuss how to talk about safety concerns with patients.

The author of a new study on JAK inhibitors discusses his surprising findings on the safety profiles of these new medications for dermatologic conditions.